logo
The MAHA Crowd Is Already Questioning Biden's Cancer Diagnosis

The MAHA Crowd Is Already Questioning Biden's Cancer Diagnosis

Yahoo19-05-2025

This article was featured in the One Story to Read Today newsletter. Sign up for it here.
It took just a few hours for devotees of the 'Make America healthy again' movement to question former President Joe Biden's prostate-cancer diagnosis. Tumors of the prostate are the most common serious malignancy identified in men: Even aggressive ones like Biden's are diagnosed roughly 25,000 times a year in the United States. Although Biden's condition is conventional, a certain segment of the public has been beguiled into blaming mainstream medicine for every unexpected death or health-related tragedy it comes across. The anti-vaccine community, including the group formerly led by Health Secretary Robert F. Kennedy Jr., has spent years promoting the idea that mRNA vaccines for COVID regularly push tumors into overdrive. (Rare anecdotes aside, there is no evidence to support this fear.) Now, predictably, the claim is cropping up again on social media. 'Prostate cancer takes years to metastasize to bone unless super aggressive or turbo cancer,' the Kennedy-endorsed physician Craig Wax suggested.
That an 82-year-old man who had aged out of prostate-cancer-screening tests has been found to have an advanced malignancy should not be surprising. In my experience as a doctor who diagnoses cancer, many tumors are discovered out of the blue. Prostate cancer in particular may not become apparent until an individual goes to his doctor with a minor complaint—in Biden's case, urinary symptoms, according to the announcement—only to have further testing discover the worst. (Biden's cancer isn't curable; people with Stage 4 disease like his live for about three years on average—although the outlook is worse for men who are more than 80 years old.)
Cancer is an enigmatic disease, one that is simultaneously influenced by genetics, environment, personal habits, the aging process, and—not to be discounted—bad luck. But its muddled nature can be uncomfortable for those who share the view that nearly all sickness is preventable with virtuous behavior and a clean environment. According to Kennedy, the current leader of the U.S. health-care system, tumors are a product of not only the vaccines in our arms, but also the fluoride in our water, the toxins in our school lunches, the signals from our phones, and surely many other ubiquitous aspects of modernity. Indeed, in MAHA land, cancer is not just a misfortune, but a cover-up. Before he became health secretary, Kennedy ominously suggested that doctors might find its cause in the 'places they dare not look.'
[Read: The inflated risk of vaccine-induced cardiac arrest]
It's not just Kennedy. Trump's health-care team routinely draws from the logic of this wellness-paranoia complex. Last year, Marty Makary, who has since become the FDA commissioner, told a group of MAHA wellness influencers convened by Senator Ron Johnson that cancer is a consequence of 'low-grade chronic inflammation' induced by a poisoned food supply. (Years ago, he also speciously declared that undetected medical errors were a leading cause of death.) Casey Means, Trump's new nominee for surgeon general, has claimed that 'the biggest lie in healthcare' is that high blood sugar, malignant tumors, and clogged arteries 'are totally different diseases requiring separate doctors and pills for life.' The truth is 'simpler than we are told,' she said. (Buy her book to find out what it is.) And Mehmet Oz, the former lifestyle guru and current Medicare administrator, recently informed Americans, 'It's your patriotic duty to be as healthy as you can. It's our job to help you get there, make it easy to do the right things.' Never mind that you can do everything right and still get sick. (For now, none of the administration's major health officials has weighed in on Biden's diagnosis.)
[Read: Did a famous doctor's COVID shot make his cancer worse?]
Joe Biden is no stranger to tough luck. His son Beau died of a brain tumor at age 46 in 2015, leading to Biden's participation in a government-funded 'cancer moonshot' to combat the condition. The moonshot initiative was an old-fashioned approach to medicine, one that sought to ameliorate illness through advances in science and technology. RFK Jr. and his MAHA acolytes are naturally suspicious of this approach. Now their weird discomfort with disease—and their outré views on cancer in particular—is being refracted through a sea of false, indecent speculations. No, Biden's cancer was not 'courtesy of the mRNA shot.' One can only hope that the government's bevy of vaccine skeptics will be able to resist the siren's call to join in saying otherwise.
Article originally published at The Atlantic

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Minnesota state workers say they're ready to strike over return-to-office — and other labor news
Minnesota state workers say they're ready to strike over return-to-office — and other labor news

Yahoo

time19 minutes ago

  • Yahoo

Minnesota state workers say they're ready to strike over return-to-office — and other labor news

Members of the Minnesota Association of Professional Employees picket in St. Paul on Wednesday, June 4. (Photo by Izzy Wagener/Minnesota Reformer) Take a seat in the Break Room, our weekly round-up of labor news in Minnesota and beyond. This week: State workers say they're strike ready; Job Corps students face homelessness; Minnesota surpasses 3 million jobs in 2024; and doctors and nurses picket across the state. State employees picketing outside negotiations between Minnesota budget officials and their union on Wednesday said they were absolutely willing to strike over Gov. Tim Walz's part-time return-to-office order that took effect this week. 'One-hundred percent I would. We can't just roll over here,' said Erin Malone, an auditor for the Department of Revenue, at a demonstration in St. Paul with more than 50 workers and supporters on Wednesday. The two unions representing nearly 40,000 state workers — the Minnesota Association of Professional Employees and the American Federation of State, County and Municipal Employees — are also fuming over the state's health care proposals they estimate will raise many workers' costs by thousands of dollars a year. The administration says rising health care costs leave them no choice. The soonest state employees could strike is in late summer, once contracts expire on June 30, they complete 45 days of mediation and then provide 10 days notice. The union explained those details in a FAQ for their members posted late last month in another sign that negotiations are headed toward a volatile impasse. State employees haven't gone on strike since walking off the job for two weeks 2001, but MAPE President Megan Dayton says she's never seen her members so fired up by Walz's unilateral decision to force workers back to the office. Hundreds of workers showed up to multiple demonstrations organized by the union over two days this week. Under Walz's order, state employees must work in the office at least 50% of the time unless they live more than 50 miles away or receive an exemption. Walz argues the policy will improve collaboration, mentorship and workplace culture, with the added benefit of bringing bodies and dollars back to a forsaken downtown St. Paul. The policy officially began June 1, but some agencies have delayed implementation as they make space for employees to return. After the COVID-19 shifted office jobs to workers' homes, state agencies began downsizing their office footprint in anticipation of permanent remote work. The Department of Revenue, for example, reduced its leased office space by 35% since 2021, saving $2.45 million annually. Many workers argue they're more productive at home and complain that the order adds to their costs in parking and gas. Some also question the motive, suspecting Walz could be distancing himself from public unions ahead of another run for governor — or trying to nudge workers off the payroll as the state stares down fiscal uncertainty. The state has also proposed changing contract language to make it easier to lay off workers in the event of 'fiscal exigencies' such as federal funding cuts, as well as epidemics, natural disasters and national security emergencies. 'I think it's political posturing,' said Christine Retkwa, a data analyst at the Department of Human Services. 'It can't be collaboration if we've been more productive… It's not to save costs.' Walz's relationship with public sector unions, which have historically been an important political ally, have soured rapidly since he announced the policy in March without consulting the unions. The union compared Walz to Elon Musk, and Walz did not invite anyone from the union to attend his State of the State Address. Tens of thousands of students at Job Corps centers across the country are facing homelessness after the Trump administration's Labor Department announced it will eliminate the vocational training program for low-income teenagers and young adults. 'You don't hit the ground running, you just hit the ground period. Straight homeless – nothing. Just straight into the ground,' Tyrone Bills, one of more than 150 students at the Hubert H. Humphrey Job Corps Center in St. Paul, told Fox 9. Last Friday, the Labor Department gave students a week's notice to move out and abandon their free training to fill jobs in manufacturing, construction, law enforcement, health care and other high-growth industries. The department later extended the deadline, and then a federal judge blocked the Trump administration from killing the program. By then, many students had already moved out. Labor Secretary Lori Chavez-DeRemer, once an advocate for Job Corps, justified eliminating the $1.7 billion program because of 'serious incidents' as well as high costs and low student graduation rates. Just 38% of students graduate, with an average cost of more than $80,000 a year, according to the agency. The National Job Corps Association disputed these figures, saying graduation rates before COVID-19 have historically been above 60% while the cost is less than $50,000 per enrollee. Minnesota continued to have one of the country's strongest labor markets in 2024, adding 40,000 non-farm jobs to push the state above 3 million jobs for the first time, according to the second annual State of Working Minnesota report from the labor-backed think tank North Star Policy Action. In the Midwest, Minnesota has the highest median wages, the highest share of workers in unions and the highest rate of health insurance coverage. The state also has the lowest unemployment rate for Black residents in the region and the lowest fatal injury rate on the job. Wage inequality also declined, while union membership increased by nearly 7% (although this can fluctuate from year to year due to imprecise data, and the general trend has been down for unions.) Support for unions is near historic highs, and that's helped nearly triple the number of union elections over the past five years, according to the report. It wasn't all good news: unemployment ticked up while the median wage moved down from $26.43 to $25.52 in an unusual break from a nearly exclusive upward trend. There is also cause for concern, according to report author Aaron Rosenthal, given federal Republicans' drive to reduce spending on health insurance for the working poor to offset some of the costs of tax cuts largely benefitting the wealthy. Working families are increasingly reliant on health insurance through Medical Assistance, the state's version of Medicaid. The number of people insured through Medical Assistance in families with at least one full-time worker increased 165% over the past 15 years. In rural areas, roughly 18% of adults and 37% of children are insured through Medical Assistance, compared to 15% of adults and 30% of children in the Twin Cities metro area. National jobs data released on Friday showed hiring has slowed as Trump's trade war and federal cuts have put employers on edge, with nearly all of the 139,000 job gains for the month being concentrated in health care and hospitality. The federal government lost 22,000 jobs. In a first for Minnesota, newly unionized doctors, physician assistants and nurse practitioners picketed outside several Allina clinics on Tuesday as negotiations stalled over a first labor contract. (It was an informational picket and not a strike.) Frustrated with what they describe as factory-style health care, the clinicians voted by a wide margin to unionize with Doctors Council SEIU in October 2023, forming the nation's largest private-sector doctors union with more than 600 members across 60 Allina clinics in Minnesota and Wisconsin. But since then, union leaders say they've made little progress toward finalizing a first labor contract covering wages, benefits and working conditions — despite meeting with hospital leaders nearly 40 times. 'We're not seeing Allina come to the table with meaningful proposals,' said Dr. Chris Antolak, a family physician, outside Allina's clinic in Coon Rapids. Unionized nurses also took to the picket lines outside 11 hospitals in the Twin Cities and two in Duluth in their push for greater staffing levels to protect themselves from workplace violence and improve patient care. The Minnesota Nurses Association is negotiating contracts covering roughly 15,000 nurses at seven of the state's largest health systems. Contracts expired on May 31 at St. Luke's and Essentia in Duluth and will expire at the end of this month at Twin Cities hospitals run by Allina, Children's, M Health Fairview, HealthPartners and North Memorial. Union president Chris Rubesch has said a strike is on the table.

Intermountain Health launches cancer treatment program for patients with advanced melanoma skin cancer
Intermountain Health launches cancer treatment program for patients with advanced melanoma skin cancer

Yahoo

time19 minutes ago

  • Yahoo

Intermountain Health launches cancer treatment program for patients with advanced melanoma skin cancer

SALT LAKE CITY, Utah (ABC4 Utah) – May is Melanoma Awareness Month and Intermountain Health is unveiling an exciting new treatment program for Utahns with advanced melanoma cancer – the first time local patients have been treated with this advanced technology and new therapy in the Beehive State. Thanks to this new cutting-edge personalized cancer treatment program, Utahns who have advanced melanoma cancer no longer have to leave the state to get a groundbreaking new treatment that is showing promise for patients with the deadliest type of skin cancer. Intermountain Health has launched a new program to provide tumor-infiltrating lymphocyte (TIL) therapy to treat patients with a type of skin cancer called unresectable or metastatic melanoma that cannot be removed surgically or has spread to other parts of the body. It is the first time this therapy has been used to treat patients in Utah. This novel therapy works by using special immune cells, called lymphocytes, which are taken from the tumor itself. These cells are then multiplied in a lab and put back into the patient's body to help fight the cancer. As part of the treatment process, doctors use AMTAGVI, the first and only FDA-approved prescription medication for the treatment of advanced melanoma that has not responded to standard therapies. AMTAGVI activates the patient's own immune system to target and destroy cancer cells and represents a different approach compared to other immunotherapies. Instead of broadly stimulating the immune system, it harnesses a patient's own tumor-specific T cells to directly target and destroy cancer cells. Intermountain Health cancer experts say the groundbreaking treatment marks a significant advancement in the fight against advanced melanoma, offering a new option for patients with limited treatment alternatives. 'We're excited to offer this advanced therapy and the hope it provides for improved outcomes for patients who have not responded to standard therapies,' said Tawnya Bowles, MD, a surgical oncologist at Intermountain Health. 'The promise for patients is that this treatment will work against their advanced melanoma when other treatments have failed. These patients do not have as many treatment options once their tumor has progressed on standard treatments. This therapy offers new hope for these patients.' TIL therapy has been used for decades, but AMTAGVI allows the treatment to extend beyond select treatment centers by using a protocol that lets a patient's tumor T cells grow at centralized facilities in the United States. Previously, only limited academic facilities with lab facilities could grow and expand the T cells. For Utahns, having the therapy program available locally is a major advancement. Not only does Utah have the highest incidence of melanoma in the nation, but until now, Utahns needing TIL therapy had to travel out of state for their care. 'Each year we see Utah patients who need this next step of treatment for advanced melanoma, and these patients previously had to leave the state and incur the expense of travel and the increased stress of being away from home,' said Caroline Nebhan, MD, PhD, Intermountain Health medical oncologist. 'We're thrilled to be able to offer this advanced treatment close to home with our Intermountain Health oncology team.' Patients in the new Intermountain treatment program are supported by a multi-disciplinary team of clinicians, including oncology experts and patient navigators, who work closely with patients throughout their treatment. The therapy involves surgically removing a sample of the patient's tumor, from which tumor-infiltrating lymphocytes (TILs) are extracted. These TILs, which are immune cells capable of recognizing and attacking cancer cells, are then sent to a specialized manufacturing facility where they are expanded and multiplied into billions of cells. Once the manufacturing process is complete (approximately 34 days), the patient undergoes a short course of lymphodepleting chemotherapy to prepare their body for the infusion of the expanded TILs. Following the AMTAGVI infusion, patients may receive several doses of interleukin-2 (IL-2) to further stimulate the activity and growth of the infused T cells. Patients are cared for in the hospital for a period to monitor for potential side effects. Research results of the medication were promising. Clinical trial data supporting FDA approval of AMTAGVI demonstrated promising response rates and, in many cases, prolonged outcomes in patients with advanced melanoma, suggesting the potential for long-term control of the disease. 'We're committed to providing our patients with access to the most advanced and innovative cancer treatments,' said Dr. Bowles. 'The addition of AMTAGVI to our comprehensive oncology program underscores this commitment and offers new hope for patients battling advanced melanoma.' To learn more about cancer care at Intermountain Health, go to Close Thanks for signing up! Watch for us in your inbox. Subscribe Now Sponsored by Intermountain Health. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Health insurers seeking steep rate increases
Health insurers seeking steep rate increases

Boston Globe

time34 minutes ago

  • Boston Globe

Health insurers seeking steep rate increases

Gov. Maura Healey, too, linked the merged market proposal to broader economic concerns. Advertisement 'Health care costs, as reflected in the proposed rates filed by health insurers, are simply unsustainable. I directed our Insurance Commissioner to closely scrutinize these filings as part of the rate review process,' Healey said in a statement to the News Service. 'What is clear is that we all must do much more to lower the cost of health care in this state.' Eight major health insurance providers late last month submitted the proposed rates they want to charge next year in the merged market, which combines under one umbrella individual insurance and small group insurance for businesses with no more than 50 eligible employees. The new annual weighted average base rates would all increase by varying amounts, with Fallon Community Health Plan's 9.9 percent the lowest and Boston Medical Center Health Plan's 16.2 percent the highest, according to DOI data. Advertisement Taken together, the proposals reflect an average increase of 13.4 percent affecting more than 720,000 renewing members, a sizable jump over the 8.36 percent growth regulators approved last year and the 4.8 percent growth in 2024. Eileen McAnenny, president of the Employer Coalition on Health, said those hikes would be 'very difficult for small businesses to absorb,' especially as employers navigate high costs for energy and unemployment insurance as well as the prospect of tariffs. 'Those rate increases are alarming when considered in the context that Massachusetts already has the second-highest health insurance premiums in the nation,' she said. 'But unfortunately, I don't think it's surprising given that we set a cost growth benchmark each year that providers and drug companies blow through without consequence, and that we keep providing supplemental payments to providers and expecting nothing in return — no improved efficiency, no transparency.' Retailers Association of Massachusetts President Jon Hurst said the 'vast majority' of his group's 4,000 members would be affected by increases in the merged market premium rates. 'The average small business in the retail, small restaurant world has sales today equal to pre-COVID. Their sales are flat, but their costs are through the roof, primarily health insurance,' Hurst said. 'We've seen, over the last five years, an increasing number of dark storefronts. It's still continuing long past COVID because of these cost increases, and health insurance premiums are by far the biggest nut.' DOI will review each of the eight rate filings individually, and the department can reject proposals if it finds that the increases are 'not reasonable in relation to health plan benefits, or if they are excessive or inadequate or use rating factors that are discriminatory or not actuarially sound,' the department wrote in an advisory. Advertisement Last year, several carriers DOI plans a virtual public hearing on June 17, where insurance carriers will present their proposals and others are invited to offer testimony, ahead of a final decision expected in August. 'We're going to tell them it's unaffordable, reject them. They can reject them,' Hurst said. 'Maybe the insurers need to go back to the drawing board and reopen these contract negotiations with hospitals and pharma companies.' The vast majority of the merged market rate increases would be driven by increasing medical and pharmacy claims, according to data insurers submitted to the state, with administrative costs, taxes and fees accounting for less than one-tenth of the total average hike. Individual and small group health plans are required to spend 88 percent of premium dollars on health care services instead of administrative or other costs. Insurers have long contended their hands are tied by high provider and prescription drug prices. Lora Pellegrini, president of the Massachusetts Association of Health Plans group that represents insurers, said carriers 'are frustrated, too.' 'Premiums reflect those underlying health care costs. We have seen rate demands from providers in the high double digits. We have one provider who's asked for a 70 percent increase in their rate. Plans can only do so much,' Pellegrini said. 'The power of providers who have only gotten bigger and bigger with consolidation make it very hard for health plans to negotiate a robust deal, because consumers want these hospital systems in their networks.' Advertisement Pellegrini pointed to financial headaches at MassHealth and the Group Insurance Commission, the latter of which needed 'Private-sector health plans have those same challenges,' she said. Margins for private health insurers have been steadily declining. After peaking at 2.8 percent in 2020, the median private health insurer total margin dropped into the red in 2023 and fell again to -1.06 percent in 2024, according to data MAHP shared with the News Service. Financial strain is rampant across the health care landscape. Total health care spending per capita in Massachusetts The Division of Insurance has already flexed new authority to scrutinize health care costs. A market oversight law Healey signed in January tasked the office's regulators with determining whether proposed rates are 'excessive' by considering 'affordability for consumers and purchasers of health insurance products.' On March 12, the division 'We are actively looking at other actions we can take to contain these health costs,' Healey said. 'Everyone has a role to play – insurers, hospitals, the pharmaceutical industry – and everyone will need to step up to make Massachusetts a more affordable place to live and do business.' Advertisement Healey and the Legislature last term agreed on a hospital oversight and market review law and a measure intended to rein in prescription drug costs. While implementation of those laws unfolds, policymakers are weighing additional action to address what Asked how confident she is that Beacon Hill Democrats can navigate the thicket of competing interests to achieve additional reforms, McAnenny replied simply, 'I hold out hope.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store